Figure 7.
A detailed evaluation of the individual species of sphingomyelins (SM), sphingosine (SPH), and phytosphingomelins (phSM) species in patients with MCI compared to the NC group of T2DM patients. Among 66 SM species evaluated in the targeted lipidomics, none of the species showed significant variations between the two studied groups (A). Similarly, analysis of 4 SPH species (B) and 2 phSM species (C) demonstrated no significant difference between the two groups.